Standout Papers

LBA34 Primary results from the phase III LEAP-002 study: Len... 2019 2026 2021 2023 1.2k
  1. LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC) (2022)
    Masatoshi Kudo, Philippe Merle et al. Annals of Oncology
  2. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2022)
    Arndt Vogel, John Bridgewater et al. Annals of Oncology
  3. CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC) (2019)
    Thomas Yau, Richard S. Finn et al. Annals of Oncology
  4. Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial (2019)
    Richard S. Finn, Baek‐Yeol Ryoo et al. Journal of Clinical Oncology
  5. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline (2019)
    Rachna T. Shroff, Erin B. Kennedy et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 151 standout
Sub-graph 1 of 18

Citing Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Precision treatment in advanced hepatocellular carcinoma
2024 Standout
45 intermediate papers

Works of Julien Edeline being referenced

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
2019 Standout
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
2011
and 16 more

Author Peers

Author Last Decade Papers Cites
Julien Edeline 2828 2214 3371 192 6.7k
Lorenza Rimassa 3181 1608 2671 264 6.5k
Jinsil Seong 1778 1387 2818 244 5.2k
Joong‐Won Park 2179 1899 5264 162 8.2k
Anthony B. El-Khoueiry 3491 1562 2034 302 6.3k
Thomas Gruenberger 6525 2696 6153 189 9.9k
Yehuda Z. Patt 2032 1209 2112 116 4.9k
Taku Aoki 2123 1708 3833 219 6.8k
Baek‐Yeol Ryoo 4660 3192 3734 348 9.8k
Yun Shin Chun 3653 1500 3363 183 5.9k
Jean‐Frédéric Blanc 1955 1147 2799 159 6.6k

All Works

Loading papers...

Rankless by CCL
2026